Xarelto and Richter's syndrome - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Xarelto?
Xarelto has active ingredients of rivaroxaban. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 206,327 Xarelto users.
What is Richter's Syndrome?
Richter's syndrome (hairy cell cancer changes in fast growing b cell cancer tumour) is found to be associated with 212 drugs and 96 conditions by eHealthMe. Currently, we are studying 1,233 people who have Richter's syndrome.
Do you take Xarelto and have Richter's syndrome?Check whether Richter's syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Xarelto side effects by duration, gender and age:
- Xarelto side effects (206,327 reports)
Richter's syndrome treatments and more:
- Richter's syndrome (1,233 reports)
All the drugs that are associated with Richter's syndrome:
All the conditions that are associated with Richter's syndrome:
How the study uses the data?
The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pepcid and Zejula drug interaction - 2 seconds ago
- Venlafaxine Hydrochloride and Remodulin drug interaction - 2 seconds ago
- Zelnorm and Septra Ds drug interaction - 3 seconds ago
- Ventolin and Cystitis Interstitial - 16 seconds ago
- Lactulose and Vessel Puncture Site Haemorrhage - 16 seconds ago
- Plaquenil and Lotrel drug interaction - 17 seconds ago
- Flexeril and Dyspnea Exertional - 23 seconds ago
- Pemetrexed and Mycostatin drug interaction - 24 seconds ago
- Clopidogrel and Low Cardiac Output Syndrome - 27 seconds ago
- Glucophage and Upper Limb Fracture - 28 seconds ago